Omkar Speciality Chemicals is currently trading at Rs. 129.65, up by 1.40 points or 1.09% from its previous closing of Rs. 128.25 on the BSE.
The scrip opened at Rs. 130.95 and has touched a high and low of Rs. 130.95 and Rs. 128.00 respectively. So far 45604 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 139.95 on 07-Mar-2014 and a 52 week low of Rs. 68.70 on 03-Oct-2013.
Last one week high and low of the scrip stood at Rs. 130.95 and Rs. 117.55 respectively. The current market cap of the company is Rs. 254.58 crore.
The promoters holding in the company stood at 64.04% while Institutions and Non-Institutions held 9.74% and 26.22% respectively.
Omkar Speciality Chemicals has completed the new project located at Unit No VI, Lote Parshuram Industrial Area, Ratnagiri district in state of Maharashtra. The company has also proposed to start the trial runs followed up by regular commercial production very shortly.
The said plant, with a capacity of 300 MTs per annum, will manufacture advance intermediates for the pharma industry catering to essential life-saving drugs with the state of the art facility for production and quality control. This facility will also contribute significantly to the company’s exports.
Omkar Speciality Chemicals is mainly engaged in the manufacture and sale of speciality chemicals viz., selenium compounds, iodine compounds, molybdenum compounds etc. and pharma intermediates viz., Potassium Iodate, Bismuth Ammonium Citrate, Bromoform etc.
| Company Name | CMP |
|---|---|
| BASF India | 4035.90 |
| Tata Chemicals | 782.10 |
| SRF | 2780.75 |
| Pidilite Inds. | 1476.15 |
| Deepak Nitrite | 1875.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: